Sanofi (SNY) Divestments (2024 - 2025)
Sanofi (SNY) posted Divestments of -$41.9 million for Q4 2025, little changed sequentially from -$42.1 million in Q3 2025, and up 64.02% YoY from -$25.5 million in Q4 2024.
Sanofi (SNY) Divestments (2024 - 2025) Analysis & Trends
Sanofi has reported Divestments for 2 years, with the latest figure at -$41.9 million in Q4 2025.
- Quarterly Divestments rose 64.02% year-over-year to -$41.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$692.3 million (changed N/A YoY) and the FY2023 annual result came in at $45.4 million, down 67.83% from the prior year.
- Divestments was little changed at -$41.9 million in Q4 2025 per SNY's latest filing, from -$42.1 million in the prior quarter.
- Over five years, Divestments peaked at -$9.5 million in Q1 2025 and troughed at -$2.0 billion in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | - |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | - |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 62.00 Mn |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | - |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | - |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 1.88 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | - |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -41.91 Mn |
| Sep 30, 2025 | -42.09 Mn |
| Jun 30, 2025 | -598.81 Mn |
| Mar 31, 2025 | -9.47 Mn |
| Dec 31, 2024 | -116.48 Mn |
| Jun 30, 2024 | -2.02 Bn |
| Mar 31, 2024 | -9.78 Mn |